Mogy Joel R Investment Counsel Inc. Trims Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mogy Joel R Investment Counsel Inc. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 66,103 shares of the medical equipment provider’s stock after selling 903 shares during the quarter. Intuitive Surgical makes up about 1.7% of Mogy Joel R Investment Counsel Inc.’s holdings, making the stock its 21st biggest holding. Mogy Joel R Investment Counsel Inc.’s holdings in Intuitive Surgical were worth $22,301,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in ISRG. Investment Partners LTD. boosted its holdings in shares of Intuitive Surgical by 5.1% during the 4th quarter. Investment Partners LTD. now owns 1,095 shares of the medical equipment provider’s stock valued at $369,000 after buying an additional 53 shares in the last quarter. Addison Advisors LLC boosted its holdings in shares of Intuitive Surgical by 52.5% during the 4th quarter. Addison Advisors LLC now owns 311 shares of the medical equipment provider’s stock valued at $105,000 after buying an additional 107 shares in the last quarter. Gilliland Jeter Wealth Management LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $1,670,000. Golden State Equity Partners boosted its holdings in shares of Intuitive Surgical by 19.7% during the 4th quarter. Golden State Equity Partners now owns 1,454 shares of the medical equipment provider’s stock valued at $491,000 after buying an additional 239 shares in the last quarter. Finally, Cornerstone Capital Inc. boosted its holdings in shares of Intuitive Surgical by 0.3% during the 4th quarter. Cornerstone Capital Inc. now owns 13,261 shares of the medical equipment provider’s stock valued at $4,474,000 after buying an additional 45 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 0.6 %

Intuitive Surgical stock traded up $2.21 during midday trading on Friday, hitting $375.33. The stock had a trading volume of 927,845 shares, compared to its average volume of 1,564,565. The firm’s fifty day moving average is $386.19 and its two-hundred day moving average is $345.95. The company has a market capitalization of $133.13 billion, a PE ratio of 67.75, a P/E/G ratio of 4.82 and a beta of 1.36. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. The company had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.00 EPS. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on ISRG shares. StockNews.com cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Truist Financial upped their price target on shares of Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Citigroup upped their price target on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Raymond James upped their target price on shares of Intuitive Surgical from $372.00 to $435.00 and gave the company an “outperform” rating in a research note on Thursday, January 25th. Finally, Barclays upped their target price on shares of Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research note on Thursday, January 25th. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $396.17.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 196 shares of the stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the sale, the senior vice president now directly owns 1,842 shares of the company’s stock, valued at approximately $736,800. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other Intuitive Surgical news, SVP Mark Brosius sold 196 shares of the stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the sale, the senior vice president now directly owns 1,842 shares of the company’s stock, valued at approximately $736,800. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Alan J. Levy sold 2,000 shares of the stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the sale, the director now directly owns 25,319 shares of the company’s stock, valued at $9,385,753.30. The disclosure for this sale can be found here. Insiders sold a total of 249,418 shares of company stock valued at $96,300,959 in the last three months. 0.90% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.